frenolicin b has been researched along with bibw 2992 in 1 studies
| Studies (frenolicin b) | Trials (frenolicin b) | Recent Studies (post-2010) (frenolicin b) | Studies (bibw 2992) | Trials (bibw 2992) | Recent Studies (post-2010) (bibw 2992) |
|---|---|---|---|---|---|
| 18 | 0 | 9 | 1,044 | 147 | 1,007 |
| Protein | Taxonomy | frenolicin b (IC50) | bibw 2992 (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.0361 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0168 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.037 | |
| Cytochrome P450 2E1 | Homo sapiens (human) | 0.014 | |
| Cytochrome P450 2C8 | Homo sapiens (human) | 0.037 | |
| Receptor tyrosine-protein kinase erbB-3 | Homo sapiens (human) | 0.0007 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.037 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
| Receptor tyrosine-protein kinase erbB-4 | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barf, T; Kaptein, A | 1 |
1 review(s) available for frenolicin b and bibw 2992
| Article | Year |
|---|---|
Irreversible protein kinase inhibitors: balancing the benefits and risks.
Topics: Animals; Cell Line; Humans; Protein Kinase Inhibitors; Protein Kinases; Risk; Structure-Activity Relationship; Time Factors | 2012 |